Link Pharma Chem Ltd. benchmarking: Perfomance to industry peers

Financial

	Link Pharma Chem	Beryl Drugs	Parmax Pharma
Operational Metrics
Financials
5 yr Average ROE	5.2 %	5.44 %	24.13 %
5yr average Equity Multiplier	1.99	2.12	29.23
5yr Average Asset Turnover Ratio	1.33	1.19	1.05
5yr Avg Net Profit Margin	-0.06 %	1.13 %	-11.29 %
Price to Book	0.84	1.16	0.0
P/E	82.38	834.88	0.0
5yr Avg Cash Conversion Cycle	82.44 Days	-589.78 Days	-92.25 Days
Inventory Days	64.96 Days	36.09 Days	69.37 Days
Days Receivable	72.97 Days	112.55 Days	20.01 Days
Days Payable	84.21 Days	964.25 Days	296.94 Days
5yr Average Interest Coverage Ratio	2.35	1.91	-0.77
5yr Avg ROCE	5.35 %	7.2 %	-14.3 %
5yr Avg Operating Profit Margin	3.76 %	6.72 %	2.43 %
5 yr average Debt to Equity	0.49	0.59	10.96
5yr CAGR Net Profit	n/a	19.3 %	n/a
5yr Average Return on Assets	0.6 %	1.98 %	-9.05 %
Shareholdings
Promoter Holding	51.49 %	26.38 %	30.8 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	1.46 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0